companydata.dkHealth and Happiness Research Fonden: Financial statements 2023
CVR: 40652086
Health and Happiness Research Fonden (CVR 40652086) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -283,727 and a net result of DKK -260,310 compared with DKK -1,705,462 the year before. Equity amounted to DKK 439,318. The solvency ratio was 75.1%.
- Gross Profit
- -283,727 kr.
- Profit/Loss
- -260,310 kr.
- Equity
- 439,318 kr.
- Total Assets
- 585,110 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -284 t. | -260 t. | 439 t. | 0 |
| 2022 | 180 t. | -529 t. | -1.7 mio. | 700 t. | 1 |
| 2021 | - | -575 t. | -4.1 mio. | 2.4 mio. | 1 |
| 2020 | - | 3.4 mio. | -3.1 mio. | 6.5 mio. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of September 1, 2023, Kristian Schrøder Hart-Hansen has left the board of directors of Health and Happiness Research Fonden.
As of September 1, 2023, Jakob Mosegaard Larsen has left the board of directors of Health and Happiness Research Fonden.
As of September 1, 2023, Vernon Christian Bainton has left the board of directors of Health and Happiness Research Fonden.
As of September 1, 2023, Frederik Bernt Hasling is registered as liquidator of Health and Happiness Research Fonden.
As of September 1, 2023, Mariana-Catalina Cernica has stepped down as director of Health and Happiness Research Fonden.
On September 1, 2023, Health and Happiness Research Fonden entered liquidation.
Health and Happiness Research Fonden has published its annual report for 2022. Revenue came to DKK 180,073, and the net result was DKK -1,705,462.
About Health and Happiness Research Fonden
Health and Happiness Research Fonden was a Danish company of the type Erhvervsdrivende fond based in København K, founded in 2019. The company was registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Frederik Bernt Hasling. In 2025, the company reported a gross profit of DKK -86,147 and a net result of DKK -81,841 compared with DKK -201,507 the year before. Equity amounted to DKK 155,970.